Skip to main content
Fig. 4 | BMC Endocrine Disorders

Fig. 4

From: Inhibiting MAPK14 showed anti-prolactinoma effect

Fig. 4

MAPK14 siRNA reduces PRL production in GH3 cells. a Effect of MAPK14 siRNA (30, 50 or 100 nM) on MAPK14 mRNA expression levels in GH3 cells. *P < 0.05 and **P < 0.01 vs. NC, (n = 3). b Effect of MAPK14 siRNA (30, 50 or 100 nM) on PRL mRNA expression levels in GH3 cells. **P < 0.01 and ***P < 0.001 vs. NC, (n = 3). c Effect of MAPK14 siRNA (30, 50 or 100 nM) on MAPK14 and PRL protein expression levels in GH3 cells. d and e Relative protein expression of both MAPK14 and PRL were quantified and normalized to β-actin. **P < 0.01 vs. NC, (n = 3)

Back to article page